Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-03-15

FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for Lamotrigine from Alembic Pharmaceuticals Limited, sanctioning an updated approval for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)